Catalent Expands Singapore Clinical Trials Hub
Catalent plans a $4.6 million investment to expand secondary packaging and storage in Asia.
Catalent Pharma Solutions announced on Feb. 2, 2016 an investment of $4.6 million to expand its Singapore clinical supply facility by building GMP space for secondary packaging. The investment will double the ambient storage space and quadruple cold storage capacity, the company reports.
Established in 1998, Catalent’s Singapore site provides clinical supply services including project and supply chain management, comparator sourcing, clinical label printing, secondary packaging, clinical storage, import/export management, importer of record service, and returns and destruction management services. It has served as a key regional hub for studies in Australia, Singapore, Korea, Hong Kong and other countries in Southeast Asia.
Source: Catalent Pharma Solutions
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
